Literature DB >> 9803431

A pharmacokinetic study of midazolam in dogs: nasal drop vs. atomizer administration.

R J Henry1, N Ruano, D Casto, R H Wolf.   

Abstract

PURPOSE: The purpose of this investigation was to compare the pharmacokinetics of midazolam following intravenous, intranasal drop, and nasal-atomizer administration in beagle dogs.
METHODS: Six animals weighing 9-13 kg were used in a repeated-measure design, group assignment based on route of drug administration. Midazolam (1.5 mg/kg) was administered with the delivery route based on group assignment. Blood samples were obtained at baseline and at 1, 3, 5, 7, 10, 15, 20, 30, and 45 min after administration. Cerebrospinal fluid samples (CSF) were obtained at 5 and 10 min after administration. Plasma and CSF concentrations of midazolam were determined by electron-capture gas-liquid chromatography.
RESULTS: Comparison between groups and over time demonstrated that both nasal routes resulted in significantly higher CSF concentrations relative to corresponding plasma levels, and that nasal-atomizer administration produced significantly higher CSF concentrations compared to the drop approach.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9803431

Source DB:  PubMed          Journal:  Pediatr Dent        ISSN: 0164-1263            Impact factor:   1.874


  6 in total

1.  Effects of GABAA kinetics on cortical population activity: computational studies and physiological confirmations.

Authors:  Sandrine Chemla; Frédéric Chavane
Journal:  J Neurophysiol       Date:  2016-02-24       Impact factor: 2.714

2.  Superiority of TPGS-loaded micelles in the brain delivery of vinpocetine via administration of thermosensitive intranasal gel.

Authors:  Tarek A Ahmed; Khalid M El-Say; Osama Aa Ahmed; Bader M Aljaeid
Journal:  Int J Nanomedicine       Date:  2019-07-23

3.  Intranasal Oxytocin and Vasopressin Modulate Divergent Brainwide Functional Substrates.

Authors:  Alberto Galbusera; Alessia De Felice; Stefano Girardi; Giacomo Bassetto; Marta Maschietto; Katsuhiko Nishimori; Bice Chini; Francesco Papaleo; Stefano Vassanelli; Alessandro Gozzi
Journal:  Neuropsychopharmacology       Date:  2016-12-20       Impact factor: 7.853

4.  Localization and differential activity of P-glycoprotein in the bovine olfactory and nasal respiratory mucosae.

Authors:  Karunya K Kandimalla; Maureen D Donovan
Journal:  Pharm Res       Date:  2005-07-22       Impact factor: 4.200

5.  Intranasal midazolam for rapid sedation of an agitated patient.

Authors:  Gentle Sunder Shrestha; Pankaj Joshi; Krishna Bhattarai; Santosh Chhetri; Subhash Prasad Acharya
Journal:  Indian J Crit Care Med       Date:  2015-06

6.  Comparison of intranasal versus intravenous midazolam for management of status epilepticus in dogs: A multi-center randomized parallel group clinical study.

Authors:  Marios Charalambous; Holger A Volk; Andrea Tipold; Johannes Erath; Enrice Huenerfauth; Antonella Gallucci; Gualtiero Gandini; Daisuke Hasegawa; Theresa Pancotto; John H Rossmeisl; Simon Platt; Luisa De Risio; Joan R Coates; Mihai Musteata; Federica Tirrito; Francesca Cozzi; Laura Porcarelli; Daniele Corlazzoli; Rodolfo Cappello; An Vanhaesebrouck; Bart J G Broeckx; Luc Van Ham; Sofie F M Bhatti
Journal:  J Vet Intern Med       Date:  2019-10-03       Impact factor: 3.333

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.